文献
J-GLOBAL ID:201702235820030637
整理番号:17A1467000
SGLT2阻害剤empagliflozinはZDFラットにおける一次糖尿病合併症を改善する【Powered by NICT】
The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
著者 (25件):
Steven Sebastian
(Center for Cardiology, Cardiology I - Laboratory of Molecular Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany)
,
Steven Sebastian
(Center for Thrombosis and Hemostasis, Medical Center of the Johannes Gutenberg University, Mainz, Germany, Medical Center of the Johannes Gutenberg University, Mainz, Germany)
,
Oelze Matthias
(Center for Cardiology, Cardiology I - Laboratory of Molecular Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany)
,
Hanf Alina
(Center for Cardiology, Cardiology I - Laboratory of Molecular Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany)
,
Kroller-Schon Swenja
(Center for Cardiology, Cardiology I - Laboratory of Molecular Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany)
,
Kashani Fatemeh
(Center for Cardiology, Cardiology I - Laboratory of Molecular Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany)
,
Roohani Siyer
(Center for Cardiology, Cardiology I - Laboratory of Molecular Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany)
,
Welschof Philipp
(Center for Cardiology, Cardiology I - Laboratory of Molecular Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany)
,
Kopp Maximilian
(Center for Cardiology, Cardiology I - Laboratory of Molecular Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany)
,
Godtel-Armbrust Ute
(Department of Pharmacology, Medical Center of the Johannes Gutenberg University, Mainz, Germany)
,
Xia Ning
(Institute of Clinical Chemistry and Laboratory Medicine, Medical Center of the Johannes Gutenberg University, Mainz, Germany)
,
Li Huige
(Institute of Clinical Chemistry and Laboratory Medicine, Medical Center of the Johannes Gutenberg University, Mainz, Germany)
,
Li Huige
(Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany)
,
Schulz Eberhard
(Center for Cardiology, Cardiology I - Laboratory of Molecular Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany)
,
Lackner Karl J.
(Institute for Advanced Biosciences, INSERM U1209 - CNRS UMR 5309, Grenoble-Alps University and Institute for Biology and Pathology, CHU, Grenoble, France)
,
Wojnowski Leszek
(Department of Pharmacology, Medical Center of the Johannes Gutenberg University, Mainz, Germany)
,
Bottari Serge P.
(German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz, Germany)
,
Wenzel Philip
(Center for Cardiology, Cardiology I - Laboratory of Molecular Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany)
,
Wenzel Philip
(Center for Thrombosis and Hemostasis, Medical Center of the Johannes Gutenberg University, Mainz, Germany, Medical Center of the Johannes Gutenberg University, Mainz, Germany)
,
Wenzel Philip
(Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany)
,
Mayoux Eric
(Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany)
,
Muenzel Thomas
(Center for Cardiology, Cardiology I - Laboratory of Molecular Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany)
,
Muenzel Thomas
(Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany)
,
Daiber Andreas
(Center for Cardiology, Cardiology I - Laboratory of Molecular Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany)
,
Daiber Andreas
(Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany)
資料名:
Redox Biology
(Redox Biology)
巻:
13
ページ:
370-385
発行年:
2017年
JST資料番号:
W3135A
ISSN:
2213-2317
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)